切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2013, Vol. 02 ›› Issue (03) : 180 -185. doi: 10.3877/cma.j.issn.2095-3232.2013.03.010

所属专题: 文献

基础研究

野生型-p53与JunB融合基因对裸鼠肝细胞肝癌移植瘤生长抑制作用的实验研究
郭成1, 段建峰1, 刘青光1,(), 张雷1, 杨雪1, 宋涛1, 姚英民1   
  1. 1. 710061 西安交通大学第一附属医院肝胆外科
  • 收稿日期:2013-05-18 出版日期:2013-06-10
  • 通信作者: 刘青光
  • 基金资助:
    国家自然科学基金资助(81272645); 中央高校基本科研业务费专项资金(xjj2010010)

Suppression of wild-type p53 and JunB fusion gene to the growth of transplanted tumor of hepatocellular carcinoma in nude mice

Cheng GUO1, Jian-feng DUAN1, Qing-guang LIU1,(), Lei ZHANG1, Xue YANG1, Tao SONG1, Ying-min YAO1   

  1. 1. Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, China
  • Received:2013-05-18 Published:2013-06-10
  • Corresponding author: Qing-guang LIU
  • About author:
    Corresponding author: LIU Qing-guang, Email:
引用本文:

郭成, 段建峰, 刘青光, 张雷, 杨雪, 宋涛, 姚英民. 野生型-p53与JunB融合基因对裸鼠肝细胞肝癌移植瘤生长抑制作用的实验研究[J]. 中华肝脏外科手术学电子杂志, 2013, 02(03): 180-185.

Cheng GUO, Jian-feng DUAN, Qing-guang LIU, Lei ZHANG, Xue YANG, Tao SONG, Ying-min YAO. Suppression of wild-type p53 and JunB fusion gene to the growth of transplanted tumor of hepatocellular carcinoma in nude mice[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2013, 02(03): 180-185.

目的

探讨野生型(wt)-p53与JunB融合基因对裸鼠肝细胞肝癌(肝癌)移植瘤的抑制作用。

方法

分别应用携带绿色荧光蛋白(GFP)的wt-p53与JunB融合基因质粒和脂质体Lipofectmine 2000(融合基因载体)、携带GFP的空质粒和Lipofectmine 2000(空载体)及单纯Lipofectmine 2000转染HepG2肝癌细胞。应用G418筛选抗生素培养基筛选阳性克隆,应用逆转录聚合酶链反应进行阳性克隆鉴定。将18只BALB/c裸鼠按随机数字表法随机分为实验组、阴性对照组和空白对照组,每组6只,分别取融合基因载体、空载体转染的HepG2肝癌细胞及单纯的HepG2肝癌细胞接种裸鼠,将2×107个肿瘤细胞悬液皮下注射至裸鼠右侧背部,于注射后的28 d处死荷瘤裸鼠,测量肿瘤体积和重量,计算肿瘤抑制率。3组裸鼠的肿瘤体积和肿瘤重量比较采用单因素方差分析,两两比较采用LSD-t检验。

结果

融合基因载体和空载体转染HepG2肝癌细胞24 h后,转染效率均达到40%。G418筛选抗生素培养基筛选10 d,融合基因载体和空载体转染的HepG2肝癌细胞出现较大的单细胞阳性克隆,扩大培养后获得稳定表达融合基因的HepG2细胞。凝胶电泳显示融合基因载体转染的HepG2肝癌细胞的p53和JunB基因表达量较空载体转染的肝癌细胞增高。融合基因载体转染的HepG2肝癌细胞的p53基因相对含量为6.09,JunB为0.13;空载体转染的HepG2肝癌细胞的p53基因相对含量为0.42,JunB为0.04。3组裸鼠移植瘤位于背侧皮下,实验组裸鼠移植瘤较小,直径为数毫米,阴性对照组与空白对照组裸鼠移植瘤均明显隆起于裸鼠背部皮下,直径介于十数毫米与数十毫米之间,移植瘤均呈菜花样突出,表面光滑无包膜,与周围组织分界明显,触之质硬,与深部组织无明显粘连,腹腔各脏器表面光滑,未见有明显的转移灶。实验组与阴性对照组移植瘤的体积分别为(47±21)mm3和(384±166)mm3,两组差异有统计学意义(LSD-t=4.638,P<0.05);两者重量分别为(2.6±0.5)g和(10.1±0.6)g,差异亦有统计学意义(LSD-t=19.560,P<0.05)。实验组与空白对照组移植瘤的体积(292±103)mm3比较,差异有统计学意义(LSD-t=5.740,P<0.05),实验组与空白对照组移植瘤的重量(9.6±0.7)g比较,差异亦有统计学意义(LSD-t=27.225,P<0.05)。实验组平均肿瘤抑制率为84%。

结论

wt-p53和JunB融合基因可明显抑制裸鼠肝癌移植瘤的生长。

Objective

To explore the suppressive effects of wt-p53 and JunB fusion gene to transplanted tumor of hepatocellular carcinoma in nude mice.

Methods

Hepatocellular carcinoma HepG2 cells were transfected by wt-p53/junB fusion gene plasmid and lipidosome Lipofectmine 2000 with green fluorescent protein (GFP) (fusion gene vector), empty plasmid and Lipofectmine 2000 with GFP (empty vector) and pure Lipofectmine 2000. The positive clone was selected by using G418 antibiotics selection culture medium and RT-PCR was performed to identify the positive clone. Afterwards, 18 BALB/c nude mice were randomly divided into experimental group, negative control group and blank control group with 6 mice in each group using computer random number table method. The nude mice in 3 groups were inoculated with HepG2 cells transfected by fusion gene vector, empty vector and pure HepG2 cells respectively and 2×107 tumor cell suspension was injected subcutaneously on the right side of nude mice's back. The nude mice were killed 28 days after injection and the gross tumor volume, tumor weight and tumor control rate were calculated. The gross tumor volume and tumor weight were compared using one-way analysis of variance and pairwise comparison was performed using LSD-t test.

Results

The transfecting rate of HepG2 cells was 40% 24 hours after transfected by fusion gene vector and empty vector. After 10 days selection by using G418 antibiotics selection culture medium, HepG2 cells transfected by fusion gene vector and empty vector acquired large single cell positive clone and fusion gene stably-expressed HepG2 cells was gained after the cultivation was amplified. HepG2 cells transfected by fusion gene vector expressed higher level of p53 and JunB gene compared with the HepG2 cells transfected by empty vector through gel electrophoresis. The gene relative amount of p53 in the experimental group was 6.09 and JunB was 0.13, while in the negative control group were 0.42 and 0.04. The transplanted tumors were located subcutaneously on the backside of nude mice of 3 groups. The tumors of mice in the experimental group were smaller with a few millimeters in diameter. The tumors of mice in the negative control group and blank control group obviously uplifted on the mice back with the diameter between ten to dozens millimeters. The transplanted tumors were cauliflower-like, had smooth surface without coating and obvious interface with surrounding tissue. The tumors were hard-texture without adhesion with deep tissue. The surfaces of abdominal organs were smooth and no obvious metastasis was observed. The gross tumor volume of mice in the experimental group and negative control group were (47±21)mm3, (384±166)mm3 respectively and there was significant difference between two groups (LSD-t=4.638, P<0.05). And the tumor weight in two groups were(2.6±0.5)g and (10.1±0.6)g respectively and there was also significant difference (LSD-t=19.560, P<0.05). There was significant difference in the gross tumor volume and tumor weight between the experimental group and blank control group [(292±103)mm3, (9.6±0.7)g] (LSD-t=5.740, 27.225; P<0.05). The tumor control rate of experimental group was 84%.

Conclusion

The growth of transplanted tumor of hepatocellular carcinoma in nude mice can be obviously inhibited by fusion gene of wt-p53 and JunB.

图1 转染24 h的HepG2肝癌细胞荧光显微镜观察图像,提示细胞内有绿色荧光蛋白表达(×100)
图2 稳定表达融合基因的HepG2肝癌细胞阳性筛选过程荧光显微镜观察图像
图3 融合基因载体和空载体转染肝癌细胞的p53和JunB琼脂糖凝胶电泳图
图4 三组裸鼠体内成瘤实验28 d的外观图像
表1 3组体内成瘤实验28 d处死荷瘤裸鼠移植瘤的体积和重量比较(±s
[1]
盖晓东,李国利,黄京子,等.野生型p53基因对肝癌细胞多药耐药的逆转作用及其相关机制.癌症, 2006, 25(8):954-959.
[2]
Boldrup L, Bourdon JC, Coates PJ, et al. Expression of p53 isoforms in squamous cell carcinoma of the head and neck. Eur J Cancer, 2007, 43(3):617-623.
[3]
Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene, 2001, 20(19):2390-2400.
[4]
Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol, 2002, 4(5):E131-E136.
[5]
Jochum W, Passegué E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene, 2001, 20(19):2401-2412.
[6]
van Dam H, Castellazzi M. Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene, 2001, 20(19):2453-2464.
[7]
Gurzov EN, Bakiri L, Alfaro JM, et al. Targeting c-Jun and JunB proteins as potential anticancer cell therapy. Oncogene, 2008, 27(5):641-652.
[8]
Pusl T, Vennegeerts T, Wimmer R, et al. Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1. Biochem Biophys Res Commun, 2008, 367(1):208-212.
[9]
da Costa Reis Monte-Mór B, Plo I, da Cunha AF, et al. Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineage. Leukemia, 2009, 23(1):144-152.
[10]
Son YO, Heo JS, Kim TG, et al. Over-expression of JunB inhibits mitochondrial stress and cytotoxicity in human lymphoma cells exposed to chronic oxidative stress. BMB Rep, 2010, 43(1):57-61.
[11]
Guo C, Liu Q, Zhang L, et al. Double lethal effects of fusion gene of wild-type p53 and JunB on hepatocellular carcinoma cells. J Huazhong Univ Sci Technolog Med Sci, 2012, 32(5):663-668.
[12]
郭成,张雷,刘青光,等.野生型p53/junB融合基因真核表达载体的构建.西安交通大学学报:医学版, 2010, 31(1):41-46.
[13]
Puca R, Nardinocchi L, Bossi G, et al. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc. Exp Cell Res, 2009, 315(1):67-75.
[14]
Andrecht S, Kolbus A, Hartenstein B, et al. Cell cycle promoting activity of JunB through cyclin A activation. J Biol Chem, 2002, 277(39):35961-35968.
[15]
Mechta-Grigoriou F, Gerald D, Yaniv M. The mammalian Jun proteins: redundancy and specificity. Oncogene, 2001, 20(19):2378-2389.
[1] 丁璐月, 刘炜, 魏昂, 张瑞东, 王天有, 刘霖霖, 臧博伦, 王亚峰, 郭明发. 贝林妥欧单抗治疗儿童复发/难治CD19+急性B淋巴细胞白血病临床观察[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 194-201.
[2] 杨玲, 徐欣欣, 周妍, 康建强, 田烨. 汽车尾气处理花粉对哮喘小鼠辅助性T细胞17/调节性T细胞的影响[J]. 中华妇幼临床医学杂志(电子版), 2016, 12(04): 383-389.
[3] 宋艳玲, 沈拓, 朱峰, 张盈帆, 苏志达, 江华. 转染SMDF基因的小鼠肌源性干细胞分化为施万样细胞的初步研究[J]. 中华损伤与修复杂志(电子版), 2018, 13(04): 260-268.
[4] 汪朦朦, 熊枝繁, 何晓晓, 邱梦君, 杨盛力. 乐伐替尼对裸鼠皮下人肝癌细胞移植瘤生长及生物钟基因表达水平的影响[J]. 中华普通外科学文献(电子版), 2019, 13(02): 90-96.
[5] 赵广峰, 朱易凡. 白细胞介素2基因转染对裸鼠乳腺癌肺转移的影响[J]. 中华普通外科学文献(电子版), 2017, 11(03): 164-167.
[6] 宁周雨, 王鹏, 陈颢, 解婧, 林钧华, 朱晓燕, 徐立涛, 陈其文, 高嵩, 宋利斌, 姜峰, 孟志强. 兔肌肉移植瘤纳米刀、冷冻、射频消融的对比实验研究[J]. 中华普通外科学文献(电子版), 2016, 10(01): 24-30.
[7] 郗文瑜, 杨静, 高健刚. Xp11.2易位/TFE3基因融合相关性肾癌两例并文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(02): 155-160.
[8] 史亮, 尹申慧, 任浩, 高荣, 马壮, 孙文武, 曹建平. 靶向核壳蛋白基因的siRNA对流感病毒的预防和治疗作用[J]. 中华肺部疾病杂志(电子版), 2020, 13(04): 461-465.
[9] 刘锴. 无异源培养条件下人多能干细胞系H1非病毒转染方法的比较和优化[J]. 中华细胞与干细胞杂志(电子版), 2021, 11(05): 305-310.
[10] 刘菊芬, 阮光萍, 李自安, 王金祥, 庞荣清, 潘兴华. 新型慢病毒转染四种细胞及在体内示踪的研究[J]. 中华细胞与干细胞杂志(电子版), 2017, 07(04): 189-194.
[11] 刘瑞磊, 王佳妮, 张鹏, 张翘楚, 李玺, 姜华, 黄勇. SIAH2蛋白在肝细胞癌发生、发展中的作用研究[J]. 中华肝脏外科手术学电子杂志, 2014, 03(03): 189-193.
[12] 孙一, 李大伟, 张海宁. hIGF-1基因改良修饰人脐血间充质细胞的研究[J]. 中华老年骨科与康复电子杂志, 2018, 04(06): 346-351.
[13] 贾祎佳, 孙吉平, 刘强, 郝海虎, 朱剑, 吴斗. 转染音猬因子对骨髓间充质干细胞成骨分化的影响[J]. 中华老年骨科与康复电子杂志, 2018, 04(06): 341-345.
[14] 沈棋, 胡帅, 李峻, 王静华, 刘漓波, 何群. 15例Xp11.2易位/TFE3基因融合相关性肾癌的临床病理特点分析[J]. 中华临床医师杂志(电子版), 2020, 14(02): 105-109.
[15] 孟凡秀, 张琪, 姚志坚, 袁洋洋, 曾思衡, 刘畅, 李勇芳, 张英敏, 赵娜, 陆嘉慧, 张智宣, 李高凯, 于保锋, 郭睿, 王海龙, 解军, 李高鹏, 徐钧. 构建靶向性高尔基体膜蛋白高尔基体蛋白73修饰脂质体介导单纯疱疹病毒胸苷激酶诱导肝癌细胞凋亡[J]. 中华临床医师杂志(电子版), 2017, 11(19): 2273-2279.
阅读次数
全文


摘要